This document provides an overview of mucoadhesive drug delivery systems (MDDS). It discusses the basics of MDDS, including how they interact with mucus and increase drug residence time. The key mechanisms of mucoadhesion - wetting, swelling, interpenetration and bond formation - are explained. Various mucoadhesive polymer types and factors affecting mucoadhesion are outlined. Different mucoadhesive dosage forms and evaluation methods are also summarized. As an example, the document briefly describes a study that developed Eudragit S100-coated chitosan microspheres to deliver mesalamine for the treatment of ulcerative colitis in a colon-specific manner.
Powerpoint presentation on controlled drug delivery system. Its introduction, terminologies, rationale, advantages, disadvantages, selection of drug, approaches for designing controlled release formulations and physicochemical and biological properties of drug
Formulation Building blocks: Building blocks for different product formulatio...PRAJAKTASAWANT33
Building blocks for different product formulations of
cosmetics/cosmeceuticals. Surfactants - Classification and application. Emollients,
rheological additives: classification and application.
This presentation includes introduction, physiology of GIT, factors affecting GRDDS, Advantages and disadvantages, approaches to GRDDS and their mechanism, some of the marketed products using GRDDS mechanism.
GRDDS is most widely used system for controlled delivery of drugs. various approaches for GRDDS is available including
floating ,gastroadhesive,high density ,unflatable system
Powerpoint presentation on controlled drug delivery system. Its introduction, terminologies, rationale, advantages, disadvantages, selection of drug, approaches for designing controlled release formulations and physicochemical and biological properties of drug
Formulation Building blocks: Building blocks for different product formulatio...PRAJAKTASAWANT33
Building blocks for different product formulations of
cosmetics/cosmeceuticals. Surfactants - Classification and application. Emollients,
rheological additives: classification and application.
This presentation includes introduction, physiology of GIT, factors affecting GRDDS, Advantages and disadvantages, approaches to GRDDS and their mechanism, some of the marketed products using GRDDS mechanism.
GRDDS is most widely used system for controlled delivery of drugs. various approaches for GRDDS is available including
floating ,gastroadhesive,high density ,unflatable system
Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.
Mucoadhesive drug delivery system is a part of controlled delivery system.
Since the early 1980,the concept of Mucoadhesion has gained considerable interest in pharmaceutical technology.
combine mucoadhesive with enzyme inhibitory & penetration enhancer properties & improve the patient complaince.
MDDS have been devloped for buccal ,nasal,rectal &vaginal routes for both systemic & local effects.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
Mucoadhesiveinner layers called mucosa inner epithelial cell lining is covered with viscoelasticfluid
Composed of water and mucin.
Thickness varies from 40 μm to 300 μm
General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5%
Mineral salts……………………………1%
Free proteins…………………………..0.5-1%
The mechanism responsible in the formation of mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact stage)
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of bonds between the entangled chains (both known as consolidation stage)
Electronic theory
Wetting theory
Adsorption theory
Diffusion theory
Fracture theory
Advantages over other controlled oral controlled release systems by virtue of prolongation of residence of drug in GIT.
Targeting & localization of the dosage form at a specific site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
If MDDS are adhere too tightlgy because it is undesirable to exert too much force to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system
Gastro Retentive Drug Delivery system is a Novel drug delivery system which is more used to retain the drug for a longer period of time in the body and also to increase the GI transit time.
Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.
Mucoadhesive drug delivery system is a part of controlled delivery system.
Since the early 1980,the concept of Mucoadhesion has gained considerable interest in pharmaceutical technology.
combine mucoadhesive with enzyme inhibitory & penetration enhancer properties & improve the patient complaince.
MDDS have been devloped for buccal ,nasal,rectal &vaginal routes for both systemic & local effects.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
Mucoadhesiveinner layers called mucosa inner epithelial cell lining is covered with viscoelasticfluid
Composed of water and mucin.
Thickness varies from 40 μm to 300 μm
General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5%
Mineral salts……………………………1%
Free proteins…………………………..0.5-1%
The mechanism responsible in the formation of mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact stage)
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of bonds between the entangled chains (both known as consolidation stage)
Electronic theory
Wetting theory
Adsorption theory
Diffusion theory
Fracture theory
Advantages over other controlled oral controlled release systems by virtue of prolongation of residence of drug in GIT.
Targeting & localization of the dosage form at a specific site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
If MDDS are adhere too tightlgy because it is undesirable to exert too much force to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system
Gastro Retentive Drug Delivery system is a Novel drug delivery system which is more used to retain the drug for a longer period of time in the body and also to increase the GI transit time.
Introduction to Mucosal Drug Delivery SystemsAshwiniRaikar1
Introduction, Principle of bioadhesion or mucoadhesion, concepts, advantaged and disadvantages, transmucosal permeability and formulation consideration of buccal delivery systems.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Buccal drug delivery system is part of mucoadhesive drug delivery system and their principal and formulation ,mechanisam of adhesion to mucosa ,use of polymers in BDDS and permiability enhancers and evaluation parameters of buccal tablets and patchs
Avoid first pass effect,
Formulation and invitro evaluation of microspheresTejaswi Kurma
basic review on microspheres.graphics is used so derz slide within a slide ie...slides which find overlapped download for watching overlaped slides for better view
In this presentation I have mentioned whatever the possible relevant content required for the Mucoadhesive drug delivery system.
Citation Is done at the end of slide.
Content is up to date & true to my belief.
Thanks & Best Regards.
Anurag Pandey
B.Pharm (FACULTY OF PHARMACY, INVERTIS UNIVERSITY)
M.Pharm (INSTITUTE OF PHARMACY, NIRMA UNIVERSITY)
Email :- anurag.dmk05@gmail.com
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Couples presenting to the infertility clinic- Do they really have infertility...
Ndds 5 MUCOADHESIVE DRUG DELIVERY SYSTEM ppt
1. Prepared By:
Prof. SHASHANK CHAURASIYA
Bansal College of Pharmacy, Bhopal
Mucoadhesive drug delivery system
1
2. •
•
•
•
•
•
•
•
•
•
2
Introduction
Basics ,concepts & mucosal membrane.
Need of mucoadhesive DDS
Mechanism of mucoadhesion
Theories mucoadhesion Sites of
mucoadhesion Penetration enhancer
Mucoadhesive polymer
Factor affecting mucoadhesion
Advantages & Disadvantages
Mucoadhesive dosage form Evaluation
3. • Mucoadhesive drug delivery system interact with the
mucus layer covering the mucosal epithelial surface,
& mucin molecules & increase the residence time of
the dosage form at the site of the absorption.
• Mucoadhesive drug delivery system is a part of
controlled delivery system.
3
4. • Since the early 1980,the concept of Mucoadhesion
has gained considerable interest in
pharmaceutical technology.
• combine mucoadhesive with enzyme inhibitory &
penetration enhancer properties & improve the
patient complaince.
• MDDS have been devloped for buccal
,nasal,rectal
&vaginal routes for both systemic & local effects.
• Hydrophilic high mol. wt. such as peptides that cannot be
administered & poor absorption ,then MDDS is best
choice.
4
5. - Inner layers called mucosa
- Inner epithelial Cell lining
Covered with viscoelastic
fluid.
-Secreted by Goblet cells
-Composed of water and mucin
-Other components include proteins,
lipids and
mucopolysaccharides
,electrolytes
-Main role is
protective and lubricates
-Tendency substance to remain
adhered to surface
-If substance adhere to
Biological mucosal layers is
called as Mucoahesion
5
6. What is mucus ?
6
• Mucoadhesiveinner layers called mucosa inner epithelial cell
lining is covered with viscoelasticfluid
Composed of water and mucin. Thickness varies from 40
μm to 300 μm General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5% Mineral
salts……………………………1% Free
proteins…………………………..0.5-1%
•
•
•
•
•
•
•
8. Functions of mucus
8
• Protective : Particularly from its hydrophobicity
Barrier : In tissue absorption of
the drugs and influence the bioavailability.
•
• Adhesion : Mucus has strong cohesion properties
• Lubrication :keep mucosal membrane moist.
10. Mechanisms of mucoadhesion
10
• The mechanism responsible in the formation of
mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact
stage)
Step 2 : Interpenetration between the polymer chains
and the mucosal membrane
Step 3 : Formation of
bonds between the entangled chains
(both known as consolidation stage)
•
•
•
11. Step-I
• Wetting and swelling step occurs when
polymer spreads over the surface of mucosal
membrane to develop intimate contact
Swelling of polymer occur because the
components of polymer have an affinity for water
•
11
12. Step-II
• In this step the mucoadhesive polymer chain and the
mucosal polymer chains intermingle and entangles to
form adhesive bonds
Strength of bonds depends upon the degree
of penetration of the two polymer groups
•
Interpenetration of mucoadhesive and mucous polymer chains
12
13. Step-III
• This step involves formation of weak chemical bonds
between the entangled polymer chains
Bonds includes primary bonds such as covalent bonds
and secondary interactions such as
vanderWaalsand hydrogen bonds
•
13
14. • Electronic theory
• Wetting theory
• Adsorption theory
• Diffusion theory
• Fracture theory
14
15. 1) Electronic theory
-Attractive electrostatic forcesbetween
mucin network & the bioadhesive material.
15
glycoprotein
2) Wetting theory
-Ability of bioadhesive polymers to spread
& develop intimate contact with the mucous
membrane.
3) Adsorption theory
-Surface forces ( covalent bond, ionic bond, hydrogen
bond & van der waals forces) resulting in chemical
bonding
16. 4) Diffusion theory
-Physical entanglement of mucinstrands
and flexible polymer chains.
5) Fracture theory
-Analyses the maximum tensile stress develop during
detachment of the BDDS from mucosal surfaces
16
18. Penetration enhancer
• Substances that facilitate the permeation through
referred as permeation enhancers .
mucosa are
• Safe and non toxic, non irritating and non allergenic
• Pharmacologically and chemically inert
•
They should have no pharmacological activity within the body
Eg. Benzalkonium chloride , Dextran sulfate ,Fatty acid ,
,Sodium EDTA etc.
•
Propyleneglycol, Men
18
19. Mucoadhesuve polymers
19
• They are water soluble and water insoluble polymers which
are swellable networks joined by cross linking agent
Characteristic of ideal polymer
Degradation products should be non toxic and non absorbable
from GIT
Good spreadibility, wetting, swelling and
biodegradable properties
Optimum molecular weight
Non irritant to mucous membrane
Form a strongnon-covalent bond with
mucin epithelial cell surface
•
•
•
•
•
•
21. Soluble Insoluble
CMC, Sodium CMC, HPMC, MC, PVA,
PVP, etc.
Carbopol, Polyacrylicacid,PEG, etc
C) According to charge
Charged
Aminodextran, Chitosan, Carbopol,
SodiumAlginate, Pectin, SodiumCMC, etc.
Uncharged
Starch, PEG, PVA, PVP, etc.
21
22. Factors affecting mucoadhesion
A)Polymer related factors:
•
•
Molecular weight
Conc. of polymer
•
•
Flexibility of polymer chains
Presence of functional group
•
•
Spatial conformation
Cross linking density
B) Environment related factors:
pH of polymer substrate interface•
• Applied strength
C) Physiological factors:
• Mucinturn over
Disease state•22
23. Advantages
-Advantages over other controlled oral controlled
release systems by prolongation of residence of drug in
GIT.
-Targeting & localization of the dosage form at a specific
site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
virtue of
-If MDDS are adhere too tightlgy because it is undesirable to exert too much force
to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system.
Disadvantages
23
25. A) Matrix tablets-(a)Monolithic
(b)two layered tablets
In monolithic mixture of drug + swelling bioadhesive polymer
bidirectional release & outer side coated with impermeable
hyrophobic substances.
In two layered matrix tablets-
Comprises an inner layer based on bioadhesive polymer &an outer
non- bioadhesive layer containing the drug for a bi-directional
release but only local action .
In case of systemic action outer layer is inert & act as a protective layer.
B) Patches-
Greater patient complaince compared with tablets owing to their
physical flexibility that causes only minor discomfort to the patient.
25
26. C)Films-may be preferred over adhesive tablets in terms of
flexibility &comfort.
An ideal film should be flexible,elastic&soft,
without breaking due to stress from mouth movements.
D)Gels& ointments- adv.over other dosage
form is that they are easily dispersion
throughtout the mucosa.
But accuracy of drug dosing may not be as accurate.
Certainpolymer are used such as NaCMC,
xanthan,carbopol,hyaluronic acid .
They change from liquid to semisolid.
HPMC has been used as an adhesive ointment
ingredients.
26
27. METHODS OF EVALUATION
A) In vitro/ Ex vivo methods
• Methods determining tensile strength
• Methods determining shear stress
• Adhesion weight method
• Fluorescent probe method
• Flow channel method
• Mechanical spectroscopic method
• Filling liquid film method
• Colloidal gold staining method
• Viscometer method
• Thumb method
• Adhesion number
• Electrical conductance
• Swelling properties
• In vitro drug release studies
• Muco retentability studies
B) In Vivo methods
•Use of radioisotopes
•Use of gamma scintigraphy
•Use of pharmacoscintigraphy
•Use of electron paramagnetic
resonance
•(EPR) oximetry
27
28. Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan
28
microspheres for the treatment of ulcerative colitis.
Seema Badhana1, Navneet Garud2, *Akanksha Garud
•Mesalamine (5-ASA) is an anti-inflammatory drug
used to treat crohn’s disease and ulcerative colitis.
•Microspheres were prepared by the modified
emulsification method using calcium chloride as cross
linking agent. The microspheres were coated with
Eudragit S-100 by the solvent evaporation technique
to prevent drug release in the stomach.